Parkinson’s disease is the second most common neurodegenerative disease among people over 65. In fact, between two to three percent of this particular population suffers from the illness. Consequently, Parkinson’s presents a challenge for researchers. Its clinical diagnosis is based on the presence of bradykinesia (slow movement) and other motor symptoms. However, the disease also causes other symptoms. It’s also associated with a number of non-motor symptoms. Naturally, these increase the sufferer’s overall level of disability. Therefore, research tends to focus on early detection of Parkinson’s. Recent research regarding diagnostic biomarkers has used neuroimaging techniques for the early detection of…
Comments